Article
Blood clotting factor IX Nagoya 3: the molecular defect of zymogen activation caused by an arginine-145 to histidine substitution.
Thrombosis research - 15 Nov 1990
Suehiro K, Miyata T, Takeya H, Takamatsu J, Saito H, Murakawa M, Okamura T, Niho Y, Iwanaga S
Abstract excerpt
Factor IX Nagoya 3 (IX Nagoya 3) is a natural mutant of factor IX recognized in a patient with moderately severe hemophilia B. The patient had 0.60 units/ml of factor IX antigen and 2-5% of clotting activity. IX Nagoya 3 was purified from the patient's plasma by immunoaffinity chromatography with an anti-factor IX monoclonal antibody column. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
